Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors.

Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S, Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S, Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G, Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R, Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F, D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G, Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study Group.

J Autoimmun. 2020 Jan 8:102397. doi: 10.1016/j.jaut.2019.102397. [Epub ahead of print]

PMID:
31926833
2.

Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress.

Emmi G, Mannucci A, Argento FR, Silvestri E, Vaglio A, Bettiol A, Fanelli A, Stefani L, Taddei N, Prisco D, Fiorillo C, Becatti M.

Front Immunol. 2019 Dec 13;10:2877. doi: 10.3389/fimmu.2019.02877. eCollection 2019.

3.

Treating the Different Phenotypes of Behçet's Syndrome.

Bettiol A, Hatemi G, Vannozzi L, Barilaro A, Prisco D, Emmi G.

Front Immunol. 2019 Dec 6;10:2830. doi: 10.3389/fimmu.2019.02830. eCollection 2019. Review.

4.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

5.

Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Colafrancesco S, Manara M, Bortoluzzi A, Serban T, Bianchi G, Cantarini L, Ciccia F, Dagna L, Govoni M, Montecucco C, Priori R, Ravelli A, Sfriso P, Sinigaglia L; AOSD Consensus Group.

Arthritis Res Ther. 2020 Jan 9;22(1):6. doi: 10.1186/s13075-019-2094-5.

6.

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.

Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.

J Clin Med. 2019 Nov 18;8(11). pii: E2013. doi: 10.3390/jcm8112013.

7.

Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients.

Urban ML, Maritati F, Palmisano A, Fenaroli P, Peyronel F, Trivioli G, Ferretti S, De Biase C, Grayson PC, Pegoraro F, Prisco D, Romagnani P, Emmi G, Vaglio A.

Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-216258. doi: 10.1136/annrheumdis-2019-216258. [Epub ahead of print] No abstract available.

PMID:
31744824
8.

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status.

Lyons PA, Peters JE, Alberici F, Liley J, Coulson RMR, Astle W, Baldini C, Bonatti F, Cid MC, Elding H, Emmi G, Epplen J, Guillevin L, Jayne DRW, Jiang T, Gunnarsson I, Lamprecht P, Leslie S, Little MA, Martorana D, Moosig F, Neumann T, Ohlsson S, Quickert S, Ramirez GA, Rewerska B, Schett G, Sinico RA, Szczeklik W, Tesar V, Vukcevic D; European Vasculitis Genetics Consortium, Terrier B, Watts RA, Vaglio A, Holle JU, Wallace C, Smith KGC.

Nat Commun. 2019 Nov 12;10(1):5120. doi: 10.1038/s41467-019-12515-9.

9.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
10.

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y.

Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]

PMID:
31610707
11.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

12.

Subclinical and clinical atherosclerosis in rheumatoid arthritis: results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Cipriani P, Liakouli V, Iacono D, Pantano I, Margiotta DPE, Navarini L, Destro Castaniti GM, Maruotti N, Di Scala G, Picciariello L, Caso F, Bongiovanni S, Grembiale RD, Atzeni F, Scarpa R, Perosa F, Emmi G, Cantatore FP, Guggino G, Afeltra A, Ciccia F, Giacomelli R.

Arthritis Res Ther. 2019 Sep 3;21(1):204. doi: 10.1186/s13075-019-1975-y.

13.

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register.

Rossio R, Ardoino I, Franchi C, Nobili A, Mannuccio Mannucci P, Peyvandi F; REPOSI Investigators.

Intern Emerg Med. 2019 Nov;14(8):1347-1352. doi: 10.1007/s11739-019-02178-1. Epub 2019 Aug 23. No abstract available.

PMID:
31444740
14.

Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients.

Carlotta F, Raffaella R, Ilaria A, Alessandro N, Mannuccio MP; REPOSI Collaborators.

Eur J Intern Med. 2019 Oct;68:e7-e11. doi: 10.1016/j.ejim.2019.07.025. Epub 2019 Aug 10. No abstract available.

PMID:
31405773
15.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
16.

New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group.

Marvisi C, Sinico RA, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A; European EGPA Study Group.

Intern Emerg Med. 2019 Nov;14(8):1193-1197. doi: 10.1007/s11739-019-02166-5. Epub 2019 Aug 6.

PMID:
31388893
17.

Behçet's syndrome: focus on pathogenetic background, clinical phenotypes and specific treatments.

Emmi G, Prisco D.

Intern Emerg Med. 2019 Aug;14(5):639-643. doi: 10.1007/s11739-019-02154-9. Epub 2019 Jul 17. No abstract available.

PMID:
31317313
18.

Intravenous immunoglobulin therapy: a snapshot for the internist.

Vitiello G, Emmi G, Silvestri E, Di Scala G, Palterer B, Parronchi P.

Intern Emerg Med. 2019 Oct;14(7):1041-1049. doi: 10.1007/s11739-019-02150-z. Epub 2019 Jul 15. Review.

PMID:
31309519
19.

Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils.

Emmi G, Becatti M, Bettiol A, Hatemi G, Prisco D, Fiorillo C.

Front Immunol. 2019 May 14;10:1085. doi: 10.3389/fimmu.2019.01085. eCollection 2019. Review.

20.

Rituximab as Maintenance Treatment for Systemic Lupus Erythematosus: A Multicenter Observational Study of 147 Patients.

Cassia MA, Alberici F, Jones RB, Smith RM, Casazza G, Urban ML, Emmi G, Moroni G, Sinico RA, Messa P, Hall F, Vaglio A, Gallieni M, Jayne DR.

Arthritis Rheumatol. 2019 Oct;71(10):1670-1680. doi: 10.1002/art.40932. Epub 2019 Aug 30.

Supplemental Content

Loading ...
Support Center